Retour

INVENTIVA (EPA:IVA) Inventiva’s 2020 Full-Year Financial Results Presentation

Directive transparence : information réglementée

23/02/2021 22:00

04/03/2021 22:00

2020 Full-Year Results: Major advances in NASH and significantly extended...

25/02/2021 22:00

Inventiva announces collaboration on non-invasive biomarkers to identify...

24/02/2021 22:00

Inventiva to participate at several investor conferences in March 2021

23/02/2021 22:00

Inventiva’s 2020 Full-Year Financial Results Presentation

11/02/2021 22:00

Full-Year 2020: Cash position and revenues

06/01/2021 22:00

Inventiva annonce sa participation à la « 39th Annual J.P. Morgan...

05/01/2021 22:00

Inventiva announces design of Phase III clinical trial with lanifibranor...

07/12/2020 22:00

Inventiva announces the publication in the Journal of Hepatology of new...

24/11/2020 22:00

Inventiva to participate at the Piper Sandler 32nd Annual Virtual...

15/07/2020 20:40

Inventiva announces the closing of $107.7 million initial public offering...

Voir tous les communiqués de INVENTIVA